Peptron (087010) Fundamentals 2026 — Revenue Analysis | SniperIQ
Peptron (087010) is a KR-listed Healthcare company in Biotechnology with a market capitalization of ₩2.41T, trading at ₩103600.00 on the KOE. This SniperIQ fundamentals page covers Peptron's valuation, profitability (net margin -277.8%), revenue (₩5.6B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Peptron's market cap?
Peptron (087010) has a market capitalization of approximately ₩2.41T, trading at ₩103600.00 on the KOE. Market cap moves with the live share price.
What is Peptron's P/E ratio?
Peptron's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 17.7x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Peptron?
Peptron runs a net profit margin of -277.8%, a gross margin of 11.7%, and an operating margin of -379.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Peptron generate?
Peptron reported revenue of ₩5.6B for fiscal year 2025, with net income of -₩13.8B and earnings per share (EPS) of -592.85. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Peptron pay a dividend?
Peptron does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Peptron financially healthy?
Peptron carries a debt-to-equity ratio of 0.22x and a current ratio of 12.19x, with a market beta of 0.20. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Peptron a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Peptron (087010) the key facts are: market cap ₩2.41T, revenue ₩5.6B, 52-week range 98000-392500. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Peptron's full fundamentals live
Get Peptron's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.